Vivani Medical, Inc. (NASDAQ:VANI) Director Purchases $33,284.20 in Stock

Vivani Medical, Inc. (NASDAQ:VANI) Director Gregg Williams acquired 35,036 shares of the stock in a transaction that occurred on Thursday, September 14th. The stock was purchased at an average price of $0.95 per share, with a total value of $33,284.20. Following the completion of the transaction, the director now owns 118,483 shares of the company’s stock, valued at $112,558.85. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Gregg Williams also recently made the following trade(s):

• On Monday, September 18th, Gregg Williams purchased 66,743 shares of Vivani Medical stock. The shares were acquired at an average price of $0.96 per share, with a total value of $64,073.28.
• On Monday, September 11th, Gregg Williams acquired 1,854 shares of Vivani Medical stock. The stock was acquired at an average cost of $0.95 per share, for a total transaction of $1,761.30.
• On Thursday, September 7th, Gregg Williams purchased 33,700 shares of Vivani Medical stock. The stock was bought at an average price of $0.94 per share, for a total transaction of $31,678.00.
• On Tuesday, September 5th, Gregg Williams bought 4,997 shares of Vivani Medical stock. The stock was bought at an average cost of $0.93 per share, for a total transaction of $4,647.21.
• On Thursday, August 31st, Gregg Williams purchased 5,295 shares of Vivani Medical stock. The stock was bought at an average cost of $0.92 per share, with a total value of $4,871.40.

Vivani Medical Stock Up 5.7 %

Shares of NASDAQ VANI opened at $0.93 on Tuesday. Vivani Medical, Inc. has a twelve month low of $0.75 and a twelve month high of $2.98. The stock has a market cap of $47.26 million, a price-to-earnings ratio of -2.38 and a beta of 2.64. The company’s fifty day moving average is $1.11 and its 200-day moving average is $1.16.

Vivani Medical (NASDAQ:VANI) last posted its earnings results on Monday, August 14th. The company reported ($0.13) earnings per share for the quarter.

Institutional Trading of Vivani Medical

Hedge funds have recently bought and sold shares of the stock. Commonwealth Equity Services LLC acquired a new position in shares of Vivani Medical in the third quarter valued at approximately $822,000. BlackRock Inc. bought a new stake in Vivani Medical in the 3rd quarter valued at $734,000. Vanguard Group Inc. acquired a new position in Vivani Medical in the 3rd quarter worth $682,000. Evoke Wealth LLC bought a new position in Vivani Medical during the 4th quarter worth about $115,000. Finally, Millennium Management LLC raised its stake in shares of Vivani Medical by 595.2% in the 4th quarter. Millennium Management LLC now owns 138,332 shares of the company’s stock valued at $118,000 after purchasing an additional 118,433 shares during the period. 8.44% of the stock is currently owned by institutional investors and hedge funds.

Vivani Medical Company Profile

Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.